Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia : 2-year follow-up from a randomized phase 3 trial ( DASISION )
Kantarjian, Hagop M, Shah, Neil P, Cortes, Jorge E, Baccarani, Michele, Agarwal, Mohan B, Undurraga, Mar\'{\i}a Soledad, Wang, Jianxiang, Julio, Juan, Ipin, Kassack, Kim, Dong-wook, Ogura, Michinori,Volume:
119
Year:
2014
Language:
english
DOI:
10.1182/blood-2011-08-376087.The
File:
PDF, 214 KB
english, 2014